Skip to main content
SpringerLink
Log in

SGLT-2 inhibitors: risk of diabetic ketoacidosis

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Douros A, et al. Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis Annals of Internal Medicine : 28 Jul 2020. Available from: URL: https://doi.org/10.7326/M20-0289

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

SGLT-2 inhibitors: risk of diabetic ketoacidosis. Reactions Weekly 1815, 10 (2020). https://doi.org/10.1007/s40278-020-81336-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-81336-9

Search

Navigation